Last update May 11, 2019
Likely Compatibility
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Linezolid in other languages or writings:
Main tradenames from several countries containing Linezolid in its composition:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Amamanta of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
An antibacterial oxazolidinone, indicated in the treatment of skin, soft tissue and lung infections by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus and vancomycin.
Oral or intravenous administration every 12 hours.
Its use is authorized in small infants and neonates.
It is excreted in breastmilk in moderate amounts which could be significant (Lim 2017, Rowe 2014, Sagirli 2009), but it is less than one tenth of the dose used in neonates and infants.
Possible side effects are not serious or frequent.
Several experts believe that the use of this medication is probably compatible during breastfeeding (Briggs 2017, Hale 2017 p563).
Be aware of false negative results of bacterial cultures obtained from febrile infants whose mothers are on antibiotics, as well as the possibility of gastroenteritis due to altered intestinal flora (Briggs 2017, Ito 1993).